Ubs Asset Management Americas Inc Mirum Pharmaceuticals, Inc. Transaction History
Ubs Asset Management Americas Inc
- $345 Billion
- Q2 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 60,019 shares of MIRM stock, worth $2.41 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,019
Previous 41,105
46.01%
Holding current value
$2.41 Million
Previous $1.03 Million
98.84%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding MIRM
# of Institutions
172Shares Held
54.2MCall Options Held
96.1KPut Options Held
54.8K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$261 Million13.09% of portfolio
-
Janus Henderson Group PLC London, X04.99MShares$200 Million0.09% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$175 Million4.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.61MShares$145 Million2.18% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$130 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.47B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...